TD Waterhouse Canada Inc. Boosts Position in Cardinal Health, Inc. $CAH

TD Waterhouse Canada Inc. increased its position in shares of Cardinal Health, Inc. (NYSE:CAH) by 101.8% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 5,940 shares of the company’s stock after acquiring an additional 2,997 shares during the quarter. TD Waterhouse Canada Inc.’s holdings in Cardinal Health were worth $976,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Wedbush Securities Inc. lifted its position in Cardinal Health by 4.5% in the first quarter. Wedbush Securities Inc. now owns 4,859 shares of the company’s stock valued at $669,000 after buying an additional 209 shares during the last quarter. Avantax Advisory Services Inc. boosted its position in shares of Cardinal Health by 16.4% in the 1st quarter. Avantax Advisory Services Inc. now owns 9,352 shares of the company’s stock valued at $1,288,000 after purchasing an additional 1,318 shares during the period. Cetera Investment Advisers grew its stake in Cardinal Health by 7.7% during the 1st quarter. Cetera Investment Advisers now owns 111,662 shares of the company’s stock worth $15,384,000 after buying an additional 7,974 shares during the last quarter. Assetmark Inc. increased its position in Cardinal Health by 33.6% during the first quarter. Assetmark Inc. now owns 77,428 shares of the company’s stock worth $10,667,000 after buying an additional 19,473 shares during the period. Finally, Westover Capital Advisors LLC increased its position in Cardinal Health by 37.8% during the first quarter. Westover Capital Advisors LLC now owns 2,425 shares of the company’s stock worth $334,000 after buying an additional 665 shares during the period. 87.17% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently issued reports on the stock. Jefferies Financial Group set a $220.00 target price on shares of Cardinal Health and gave the stock a “buy” rating in a research report on Monday, November 3rd. Deutsche Bank Aktiengesellschaft lifted their price objective on shares of Cardinal Health from $195.00 to $208.00 and gave the company a “hold” rating in a research note on Tuesday, November 18th. Argus boosted their price target on Cardinal Health from $189.00 to $211.00 and gave the company a “buy” rating in a research report on Tuesday, November 4th. Weiss Ratings reaffirmed a “buy (b)” rating on shares of Cardinal Health in a report on Wednesday, October 8th. Finally, Wells Fargo & Company boosted their target price on Cardinal Health from $185.00 to $221.00 and gave the stock an “overweight” rating in a research report on Wednesday, November 5th. Twelve investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $206.57.

Cardinal Health Trading Up 0.7%

CAH stock opened at $209.27 on Friday. The company’s 50-day moving average price is $171.23 and its 200 day moving average price is $161.17. Cardinal Health, Inc. has a 52 week low of $114.60 and a 52 week high of $210.32. The company has a market cap of $49.72 billion, a P/E ratio of 32.45, a P/E/G ratio of 1.39 and a beta of 0.72.

Cardinal Health (NYSE:CAH) last posted its quarterly earnings results on Thursday, October 30th. The company reported $2.55 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.22 by $0.33. The company had revenue of $64.01 billion during the quarter, compared to the consensus estimate of $59.41 billion. Cardinal Health had a net margin of 0.70% and a negative return on equity of 74.45%. The company’s revenue for the quarter was up 22.4% on a year-over-year basis. During the same period last year, the firm earned $1.88 EPS. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS. On average, equities research analysts expect that Cardinal Health, Inc. will post 7.95 earnings per share for the current year.

Cardinal Health Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Thursday, January 15th. Shareholders of record on Friday, January 2nd will be issued a $0.5107 dividend. The ex-dividend date of this dividend is Friday, January 2nd. This represents a $2.04 annualized dividend and a yield of 1.0%. Cardinal Health’s dividend payout ratio is 30.77%.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.